Fabio Bagnoli – författare

The Vaccine Book: New Insights, Approaches and Technologies, Third Edition?provides comprehensive information on the current and future world of vaccines. It reveals the scientific opportunities and potential impact of vaccines, including economic and ethical challenges, problems encountered when producing vaccines, how clinical vaccine trials are designed, and how to introduce vaccines into widespread use. Although vaccines are now available for many diseases, there are still challenges ahead for major diseases such as AIDS, tuberculosis, and malaria. Edited by a new, highly experienced team of editors, the 3rd edition provides new approaches, design, and vaccine platform tools to develop vaccines quicker.This new edition is fully updated and designed for students, researchers, public health offcials, and all others interested in increasing their understanding of vaccines.

Includes new vaccines and current concepts as well as vaccine developments to prepare for new pandemicsProvides insights into diseases that could be prevented, along with the challenges facing research scientists in the world of vaccinesDelivers ideas about challenges facing public and private industrial investors in the vaccine areaDiscusses the problem of declining immunization rates and vaccine hesitancy

This edited volume discusses the application of very diverse human organotypic models in major areas of biomedical research.

This edited volume discusses the application of very diverse human organotypic models in major areas of biomedical research.

This volume offers insights into human challenge studies, where adult volunteers are deliberately infected with a pathogen of interest.

This volume offers insights into human challenge studies, where adult volunteers are deliberately infected with a pathogen of interest. These studies can broaden our knowledge on infections that have a rather low natural infection rate, but still bear a great threat to global health. The authors also present instances, where no suitable animal model is available to help understand human immune responses to a specific pathogen. The recent SARS-CoV-2 pandemic is another example, where studies that are directly conducted in humans, could save valuable time.Human challenge studies can provide immunogenicity and early efficacy data for vaccine development. However, similar models could be used for studying a wide variety of medical treatments such as monoclonal antibodies, antibiotics, antivirals and bacteriophages. The chapters in this volume cover several pathogens, including viruses, bacteria and parasites, scientific and technical aspects as well as descriptions of regulatory, ethical and manufacturing requirements.The book serves as a valuable resource for scientists and clinicians working on human pathogens.

This book focuses on the envelope of Gram-positive bacteria including its composition, the latest discoveries in the mechanisms behind its assembly, and its role in pathogenesis. Furthermore, new applications in biotechnology and vaccine development involving these bacteria are discussed in detail. This concise volume consists of eleven chapters by prominent experts in the field, which review the latest findings and current state of knowledge on a range of diverse yet interlinked aspects. This book is written for all researchers, clinicians and technicians engaged in basic or applied science projects on Gram-positive bacteria.

This volume offers a comprehensive overview of basic and applied aspects of Staphylococcus aureus, which is one of the most important human pathogens. All chapters were written by respected experts in the field – presenting recent findings on a diverse range of aspects, they are nonetheless interlinked.

This book focuses on the envelope of Gram-positive bacteria including its composition, the latest discoveries in the mechanisms behind its assembly, and its role in pathogenesis. This book is written for all researchers, clinicians and technicians engaged in basic or applied science projects on Gram-positive bacteria.